Form 8-K - Current report:
SEC Accession No. 0001641172-25-026602
Filing Date
2025-09-04
Accepted
2025-09-04 16:55:29
Documents
13
Period of Report
2025-09-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 38027
2 EX-99.1 ex99-1.htm EX-99.1 20931
  Complete submission text file 0001641172-25-026602.txt   230299

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE alts-20250904.xsd EX-101.SCH 3017
4 XBRL LABEL FILE alts-20250904_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE alts-20250904_pre.xml EX-101.PRE 22360
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3693
Mailing Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119
Business Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119 702-997-5968
ALT5 Sigma Corp (Filer) CIK: 0000862861 (see all company filings)

EIN.: 411454591 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19621 | Film No.: 251294115
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)